Profile photo

Urologic Oncology With Christopher Wallis, MD, PhD, FRCSC

Urology

Dr. Wallis is a urologic oncologist at the University of Toronto and Mount Sinai Hospital/University Health Network. He completed his Society of Urologic Oncology-accredited fellowship training at Vanderbilt University Medical Center. His clinical work and research are focused on the care of patients with prostate, kidney, bladder, and testis cancer.

SUO 2023 Wrap-Up: Late-Breaking Abstracts With Data on NMIBC

Dear readers,

What a whirlwind–we just wrapped up a fantastic Society of Urologic Oncology 2023 Annual Meeting in Washington, DC. While this newsletter will emphasize some of the biggest highlights, check out GU Oncology Now for complete coverage.

This year’s meeting featured a number of late-breaking abstracts with exciting data in non-muscle invasive bladder cancer. Check out some of these talks below.

-c

Christopher JD Wallis, MD PhD FRCSC

Articles
  • Mashup Score: 0
    Sabine D. Brookman-May on X - 1 year(s) ago

    #SUO23 Excellent results BOND-003 Phase 3 trial – intravesical oncolytic CG #immunotherapy in HR BCG unresponsive CIS +/- papillary #NMIBC 76% CR at any time  64% at 6 months  very good side effects profile @MarkTysonMD

    Tweet Tweets with this article
    • Profile photo of walliscjd
      walliscjd

      In the same session as Dr. Patel’s presentation, Dr. Mark Tyson presented results of the BOND-003 study examining the use of Cretostimogene grenadenorepvec as intravesical treatment for patients with BCG-unresponsive high-risk NMIBC with CIS.

  • Mashup Score: 0
    Focal Therapy in Localized Prostate Cancer: Progress and Novel Modalities - 1 year(s) ago

    Read the full article here

    Tweet Tweets with this article
    • Profile photo of walliscjd
      walliscjd

      Wednesday afternoon’s session featured a number of presentations on focal therapy for prostate cancer, including the FALCON consensus statement and preliminary data from the registration trial of Nanoknife irreversible electroporation. Check out my interview with the lead author Dr. Arvin George to hear his insights into the role of this treatment approach in our patients with prostate cancer.

  • Mashup Score: 0
    Jennifer Linehan, MD on X - 1 year(s) ago

    PLND vs EPLND – One of the best discussions and review of data at #SUO2023 @UroOnc @bbmdmsk Dr. Seth Lerner @SimaPorten #SUO23 @JoshMeeks @ERPlimackMD What will you continue to do for T2 MIBC?

    Tweet Tweets with this article
    • Profile photo of walliscjd
      walliscjd

      In the Friday morning session, Dr. Seth Lerner and Dr. Bernie Bochner had a point-counterpoint discussion regarding the role of extended versus standard lymphadenectomy. Dr. Linehan highlights some of the data presented here.

  • Mashup Score: 0
    Elizabeth Plimack MD on X - 1 year(s) ago

    Great advice from @Robert_Uzzo accepting the Joseph A. Smith Mentorship Award at #SUO23 Take Inventory Embrace Failure Move Forward Be Grateful Congratulations! So very well deserved. #FoxChaseProud @FoxChaseCancer @FCUroOnc

    Tweet Tweets with this article
    • Profile photo of walliscjd
      walliscjd

      On Friday morning, Dr. Robert Uzzo was honored with the Joseph A. Smith, Jr. Mentorship Award after which he presented a lecture entitled “Take Inventory, Embrace Failure, Move Forward, Be Grateful”.